Cyberjaya, 31 May 2024 - DXN Holdings Bhd. [德信控股] (“DXN” or the “Company”), a leading global manufacturer of nutraceutical products, is pleased to announce the appointment of Mr. Prajith Pavithran as the new Chief Executive Officer (“CEO”), effective 1 June 2024.
With an impressive tenure of over two decades with DXN and its subsidiaries (“DXN Group” or “Group”), Mr. Prajith, aged 45, is a seasoned sales and marketing leader with a deep understanding of the Group’s operations. As the Chief Marketing Officer, he has played a pivotal role in driving growth, particularly within the Latin American region. Under his leadership, Latin America has emerged as the Group’s fastest-growing market and the largest revenue contributor, accounting for more than 50% of the Group’s revenue.
Executive Chairman and Founder of DXN, Datuk Lim Siow Jin (拿督林孝仁) shared, “Mr. Prajith's appointment reflects DXN's strategic shift towards leadership infused with fresh energy and perspectives. His extensive experience and proven track record of driving growth in DXN's core markets makes him the ideal candidate to lead the Group forward. His deep understanding of these key markets will be invaluable in navigating the evolving business landscape and ensuring DXN Group's long-term success.”
Mr. Prajith began his career at DXN in 2001 as a Sales and Training Executive and his rapid progression had led him through various leadership roles within the Group. He oversaw operations in key markets such as India, the Philippines, and Mexico, before being appointed Regional Manager for Latin America in 2010. In this role, he spearheaded DXN’s market expansion efforts and strengthened the Group’s presence within the region. Most recently, he served as Chief Marketing Officer from May 2022, up until his new appointment as the CEO.
Mr. Prajith is assuming the leadership role previously held by Mr. Teoh Hang Ching, aged 65, who is now transitioning from CEO and Executive Director, to focus exclusively on leading DXN Group’s expansion into China. With over 17 years of service at DXN, Mr. Teoh has served in diverse capacities, including Regional Manager, Chief Operating Officer and Chief Marketing Officer.
Datuk Lim added, “China is a critical market for sustained expansion, characterised by its complexities and unique regulatory landscape. Mr. Teoh has strong knowledge of China’s local business environment, market trends and regulatory framework. He oversaw the establishment of our new cultivation and production facilities in Ningxia, China in recent years. Among DXN’s manufacturing facilities worldwide, China has the largest footprint, covering a total built-up area of 195,000 square meters. With DXN prioritising expansion in China, Mr. Teoh’s extensive experience positions him well to elevate DXN China to the next level,” he concluded.
“On this note, I expressed our sincere gratitude to Mr. Teoh Hang Ching, for his dedicated leadership and the significant contributions he has made to the Group's success globally. His ongoing efforts will be instrumental as we embark on our next chapter of growth in China. We are a strong team, and we look forward to continually working together in shaping DXN Group's future successes.”
Under Mr. Prajith's leadership and with Mr. Teoh’s continued guidance, DXN is well-positioned to navigate shifting market dynamics while ensuring sustainable growth.
Listed on the Main Market of Bursa Securities, DXN is a leading global manufacturer of nutraceutical products, blending the medicinal benefits of natural sources like edible fungi and spirulina with cutting-edge biotechnology. The Company boasts advanced R&D and cultivation facilities to enhance production processes and develop new product innovations. DXN's extensive product portfolio includes fortified food and beverages, health and dietary supplements, as well as personal care and cosmetics. With a significant global market presence, DXN operates across South America, the Middle East, North Africa, and Asia.
For more information, please visit https://www.dxn2u.com/
Copyright © 2017 - 2024, DXN Holdings Bhd. 199501033918 (363120-V)